Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMA Supply Disruption — Teva Pharmaceuticals USA, Inc
Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMA Supply Disruption — Teva Pharmaceuticals USA, Inc is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMA; Manufacturer: Teva
| Drug name | Prazosin Hydrochloride, Capsules, USP, 2 mg, Rx only, Distributed by TEVA PHARMA |
|---|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc |
| Recall/Disruption reason | CGMP Deviations-Test results for N-nitroso Prazosin impurity C that are above the Carcinogenic Potency Categorization Ap |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0105-2026 |
| Initiation date | 20251007 |
| Quantity affected | 291,512 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →